- Home
- ECPG vs BLFS Comparison
ECPG vs BLFS Comparison
Compare ECPG & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECPG | BLFS |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1999 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ECPG | BLFS |
|---|---|---|
| Price | $73.48 | $20.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $77.33 | $32.00 |
| AVG Volume (30 Days) | 218.7K | ★ 420.6K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 287.14 | 77.27 |
| EPS | ★ 10.91 | N/A |
| Revenue | ★ $1,768,802,000.00 | $96,214,000.00 |
| Revenue This Year | $3.63 | $19.20 |
| Revenue Next Year | $4.47 | $18.07 |
| P/E Ratio | $6.78 | ★ N/A |
| Revenue Growth | ★ 34.37 | 16.97 |
| 52 Week Low | $26.45 | $19.15 |
| 52 Week High | $74.58 | $29.57 |
Technical Indicators
Market Signals| Indicator | ECPG | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 86.09 | 37.91 |
| Support Level | $54.39 | $20.54 |
| Resistance Level | N/A | $23.00 |
| Average True Range (ATR) | 2.99 | 1.03 |
| MACD | 1.69 | -0.12 |
| Stochastic Oscillator | 96.80 | 18.94 |
Price Performance
Historical ComparisonAbout ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.